Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Remuneration Information 2015

Jun 16, 2015

5229_dirs_2015-06-16_814b620a-71a0-49bd-8191-a071ebc708e0.html

Remuneration Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2940Q

AstraZeneca PLC

16 June 2015

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 15 June 2015, the interest of Mr Marc Dunoyer, a person discharging managerial responsibilities, in the ordinary shares of AstraZeneca PLC changed as detailed below.

The change in interest relates to the vesting of a previously announced award of restricted shares made to Mr Dunoyer in August 2013. The award vests in three tranches over three years.

After sufficient shares were withheld to satisfy certain tax obligations arising on the vesting, Mr Dunoyer has become beneficially entitled to and has received 21,980 shares into a personal brokerage account in respect of the second tranche of the award.

For tax purposes, the fair market value of the shares at vest was 4211 pence per share being the closing price of AstraZeneca ordinary shares on the last trading day preceding the vesting day.

A C N Kemp

Company Secretary

16 June 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUNARRVSANAAR